When describing harms and benefits to potential trial participants, participant information leaflets are inadequate.
Issue Date
2024-05-01Keywords
Benefits and harmsinformed consent
Participant information leaflets
Patient information leaflets
risks
Trial methodology
Metadata
Show full item recordJournal
TrialsDOI
10.1186/s13063-024-08087-9PubMed ID
38693579Item Type
ArticleOther
Language
enEISSN
1745-6215ae974a485f413a2113503eed53cd6c53
10.1186/s13063-024-08087-9
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Related articles
- Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation.
- Authors: Gillies K, Huang W, Skea Z, Brehaut J, Cotton S
- Issue date: 2014 Feb 18
- Trial participants' self-reported understanding of randomisation phrases in participation information leaflets can be high, but acceptability of some descriptions is low, especially those linked to gambling and luck.
- Authors: Shiely F, Murphy E, Gilles K, Hood K, O'Sullivan L, Harman N, Isaacs T, Treweek S
- Issue date: 2024 Jun 18
- Retention strategies are routinely communicated to potential trial participants but often differ from what was planned in the trial protocol: an analysis of adult participant information leaflets and their corresponding protocols.
- Authors: Murphy E, Gillies K, Shiely F
- Issue date: 2024 Jun 10
- Patient information leaflets for placebo-controlled surgical trials: a review of current practice and recommendations for developers.
- Authors: Cousins S, Huttman M, Blencowe N, Tsang C, Elliott D, Blazeby J, Beard DJ, Campbell MK, Gillies K
- Issue date: 2024 May 22
- Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when.
- Authors: Bjorklund M, Shiely F, Gillies K
- Issue date: 2022